Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2013; 19(10): 1618-1624
Published online Mar 14, 2013. doi: 10.3748/wjg.v19.i10.1618
Published online Mar 14, 2013. doi: 10.3748/wjg.v19.i10.1618
Table 1 Clinical characteristics of the subjects
Sex (male/female) | 27/17 |
Age (yr), means ± SD | 69.7 ± 8.0 |
Cause of liver dysfunction | |
HBV | 5 |
HCV | 30 |
Alcoholic | 3 |
PBC | 1 |
NBNC | 5 |
Child-Pugh A/B | 33/11 |
Therapy | |
PELI | 7 |
PELI-RFA | 6 |
PEI-RFA | 18 |
RFA | 13 |
- Citation: Kobayashi M, Kinekawa F, Matsuda K, Fujihara S, Nishiyama N, Nomura T, Tani J, Miyoshi H, Kobara H, Deguchi A, Yoneyama H, Mori H, Masaki T. Influence of percutaneous local therapy for hepatocellular carcinoma on gastric function. World J Gastroenterol 2013; 19(10): 1618-1624
- URL: https://www.wjgnet.com/1007-9327/full/v19/i10/1618.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i10.1618